|
Trastuzumab-lapatinib as neoadjuvant therapy for HER2-positive early breast cancer: Survival analyses of the CHER-Lob trial |
|
|
|
Titel: |
Trastuzumab-lapatinib as neoadjuvant therapy for HER2-positive early breast cancer: Survival analyses of the CHER-Lob trial |
Auteur: |
Guarneri, Valentina Dieci, Maria V. Griguolo, Gaia Miglietta, Federica Girardi, Fabio Bisagni, Giancarlo Generali, Daniele G. Cagossi, Katia Sarti, Samanta Frassoldati, Antonio Gianni, Lorenzo Cavanna, Luigi Pinotti, Graziella Musolino, Antonino Piacentini, Federico Cinieri, Saverio Prat, Aleix Conte, PierFranco |
Verschenen in: |
European journal of cancer |
Paginering: |
Jaargang 153 () nr. C pagina's 133-141 |
Jaar: |
2021 |
Inhoud: |
|
Uitgever: |
The Authors |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|